LANGUAGE
KOREANENGLISH
LOCATION
  • COMPANY
  • R&D
    • R&D Institute
    • GMP Center
    • Clinical Development Status
    • Publications
  • PRODUCTS
    • 1st Generation
      • Overview
      • CARTISTEM®
      • PNEUMOSTEM®
    • 2nd Generation
      • Overview
      • SMUP-IA-01
      • SMUP-IV-01
    • R&D Inquiries
  • BUSINESS
    • CDMO
      • CDMO Service
      • Core Value
      • Manufacturing
      • Global CDMO
      • CDMO Inquiries
    • CELLTREE Cord Blood Bank
    • MOVITA Nutritional Supplements
    • LUCATREE Advanced Regenerative Medicine
  • IR
    • Stock Information
    • Disclosure
    • Financial Information
    • IR Inquiries
  • PR
    • MEDIPOST on Media
    • Corporate Brochure
  • CONTACT US
    • Customer Center
    • R&D Inquiries
    • CDMO Inquiries
    • IR Inquiries

Hiddink, designated MEDIPOST Cord Blood Honorary Ambassador

2014/07/23
CORD BLOOD BANK

Previously Korean National Soccer Team Manager Guus Hiddink leads vitalization of cord blood storage and donation. MEDIPOST, number 1 corporation in the cord blood storage industry, designated Guus Hiddink as ‘Cord Blood Honorary Ambassador’ at Seoul Shinra Hotel on 23 July.

Hiddink came to be the honorary ambassador to vitalize cord blood storage and donation, after receiving knee arthritis treatment and being cured in Korea in January this year with CARTISTEM® which is made from cord blood.

Hiddink was in a serious state with almost no cartilage left in the right knee, rendering normal everyday life impossible, but was known to have greatly improved after around 6 months, being able to enjoy even sports such as golf. Hiddink will partake in promotion of cord blood with MEDIPOST for 1 year, and various related social contribution activities.

VIEW LIST

Related News

news 200518
Star Actress Choi Jiwoo Stores Her Baby’s Umbilical Cord Blo…
2020/05/18
news 180108
Longer-Term Storage of Cord Blood Gains Popularity Over 20,0…
2020/04/29

Latest News

knee img
MEDIPOST Inc. Treats First U.S. Participant in Phase III Tri…
2026/07/07
cdmo img33
MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Stu…
2026/06/04
news
MEDIPOST’s CARTISTEM® Meets All Primary and Secondary…
2026/05/13
medipost img 2
MEDIPOST, INC. ANNOUNCES $140 MILLION IN FUNDING TO ACCELERA…
2026/01/09
knee img
MEDIPOST Inc. Treats First U.S. Participant in Phase III Tri…
2026/07/07
cdmo img33
MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Stu…
2026/06/04
news
MEDIPOST’s CARTISTEM® Meets All Primary and Secondary…
2026/05/13
medipost img 2
MEDIPOST, INC. ANNOUNCES $140 MILLION IN FUNDING TO ACCELERA…
2026/01/09

Contacts

21, Daewangpangyo-ro 644, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea MEDIPOST Co., Ltd.
TEL : 82-2-3465-6677

Latest News

MEDIPOST Inc. Treats First U.S. Particip…2026.07.07
MEDIPOST Secures FDA Agreement on Single…2026.06.04
MEDIPOST’s CARTISTEM® Meets All Pr…2026.05.13
MEDIPOST, INC. ANNOUNCES $140 MILLION IN…2026.01.09
MEDIPOST Announces the Exclusive Commerc…2025.12.19

Family Site

· CELLTREE Cord Blood Bank
· MOVITA Nutritional Supplements

· LOCATION
· PRIVACY POLICY

©Copyright – The Future of Biotechnology, MEDIPOST